| Cover - shares | 6 Months Ended | |
| Mar. 31, 2021 | May 26, 2021 | |
| Cover [Abstract] | ||
| Document Type | 10-Q | |
| Amendment Flag | false | |
| Document Quarterly Report | true | |
| Document Transition Report | false | |
| Document Period End Date | Mar. 31, 2021 | |
| Document Fiscal Period Focus | Q2 | |
| Document Fiscal Year Focus | 2021 | |
| Current Fiscal Year End Date | --09-30 | |
| Entity File Number | 333-174194 | |
| Entity Registrant Name | GRAPHENE & SOLAR TECHNOLOGIES LTD | |
| Entity Central Index Key | 0001497649 | |
| Entity Tax Identification Number | 27-2888719 | |
| Entity Incorporation, State or Country Code | CO | |
| Entity Address, Address Line One | 23 Corporate Plaza Drive | |
| Entity Address, Address Line Two | Suite 150 | |
| Entity Address, City or Town | Newport Beach | |
| Entity Address, State or Province | CA | |
| Entity Address, Postal Zip Code | 92660 | |
| City Area Code | 949 | |
| Local Phone Number | 432-7525 | |
| Entity Current Reporting Status | Yes | |
| Entity Interactive Data Current | No | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Small Business | true | |
| Entity Emerging Growth Company | true | |
| Elected Not To Use the Extended Transition Period | false | |
| Entity Shell Company | false | |
| Entity Common Stock, Shares Outstanding | 255,037,319 |
| Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2021 | Sep. 30, 2020 |
| Current Assets: | ||
| Cash | $ 147 | $ 12 |
| Prepaid expenses | 15,723 | |
| Total Current Assets | 15,870 | 12 |
| Other Assets: | ||
| Furniture & Equipment, net of depreciation, $8,986 and $71,803 | 4,021 | 12,259 |
| Total Other Assets | 4,021 | 12,259 |
| Total Assets | 19,891 | 12,271 |
| Current Liabilities: | ||
| Accounts payable and other payable | 785,433 | 653,476 |
| Accrued interest payable | 146,702 | 132,099 |
| Notes payable-in default | 60,000 | 60,000 |
| Due to related parties | 810,116 | 717,075 |
| Convertible notes payable-, net of discount $86,381and $52,703 in default | 202,292 | 116,264 |
| Other loans | 5,781 | 5,632 |
| Total Current Liabilities | 2,010,324 | 1,684,546 |
| Total Liabilities | 2,010,324 | 1,684,546 |
| Stockholders’ Deficit: | ||
| Common stock, $0.00001 par value; 500,000,000 and 500,000,000 shares authorized; 254,487,319 and 246,248,723 shares issued and outstanding | 2,546 | 2,463 |
| Additional paid-in capital | 13,495,049 | 9,508,943 |
| Accumulated other comprehensive income | (15,310) | 52,015 |
| Accumulated deficit | (15,472,718) | (11,235,696) |
| Total stockholders’ deficit | (1,990,433) | (1,672,275) |
| Total liabilities and stockholders’ deficit | $ 19,891 | $ 12,271 |
| Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) | Mar. 31, 2021 | Sep. 30, 2020 |
| Statement of Financial Position [Abstract] | ||
| Furniture & Equipment, net of depreciation | $ 8,986 | $ 71,803 |
| Debt Instrument, Unamortized Discount, Current | $ 86,381 | $ 52,703 |
| Preferred stock, par value | $ 0.00001 | $ 0.00001 |
| Preferred shares, authorized | 10,000,000 | 10,000,000 |
| Preferred stock, issued | 0 | 0 |
| Preferred stock, outstanding | 0 | 0 |
| Common stock, par value | $ 0.00001 | $ 0.00001 |
| Common stock, authorized | 500,000,000 | 500,000,000 |
| Common stock, issued | 254,487,319 | 246,248,723 |
| Common stock,outstanding | 254,487,319 | 246,248,723 |
| Condensed Consolidated Statements of Operations and Other Comprehensive Income - USD ($) | 3 Months Ended | 6 Months Ended | ||
| Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | |
| Income Statement [Abstract] | ||||
| Revenues | ||||
| Costs and expenses | ||||
| Professional Services | 3,545,803 | 134,237 | 4,130,354 | 313,724 |
| General and administrative | 38,801 | 29,559 | 81,350 | 85,410 |
| Total costs and expenses | 3,584,604 | 163,796 | 4,211,704 | 399,134 |
| Loss from operations | (3,584,604) | (163,796) | (4,211,704) | (399,134) |
| Other income (expense) Other income | ||||
| Interest expense | (15,551) | (15,079) | (29,827) | (22,445) |
| Total other income (expense) | (13,233) | (13,104) | (25,318) | (18,420) |
| Net Income (Loss) | (3,597,837) | (176,900) | (4,237,022) | (417,554) |
| Comprehensive income (Loss) | 15,312 | 76,505 | (67,325) | 55,404 |
| Net Comprehensive Income (Loss) | $ (3,582,525) | $ (100,395) | $ (4,304,347) | $ (362,150) |
| Income (Loss) per share: | ||||
| Basic and diluted | $ (0.01) | $ 0 | $ (0.02) | $ 0 |
| Weighted average shares outstanding | 253,168,937 | 242,953,034 | 251,406,796 | 242,626,956 |
| Condensed Consolidated Statements of Stockholders Deficit - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | AOCI Attributable to Parent [Member] | Retained Earnings [Member] | Total |
| Beginning balance, value at Sep. 30, 2019 | $ 2,424 | $ 9,047,139 | $ 100,717 | $ (10,132,535) | $ (982,255) |
| Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2019 | 242,449,767 | ||||
| Shares issued in connection with the sale of common stock | $ 3 | 52,999 | 53,002 | ||
| Stock Issued During Period, Shares, New Issues | 153,333 | ||||
| Foreign currency translation adjustment | (21,101) | (21,101) | |||
| Net Loss | (240,654) | (240,654) | |||
| Common Stock, Shares, Outstanding, Ending Balance at Dec. 31, 2019 | 242,603,100 | ||||
| Ending balance, value at Dec. 31, 2019 | $ 2,427 | 9,168,358 | 79,616 | (10,373,189) | (1,122,788) |
| Debt Discount on Convertible Notes | 68,220 | 68,220 | |||
| Beginning balance, value at Sep. 30, 2019 | $ 2,424 | 9,047,139 | 100,717 | (10,132,535) | (982,255) |
| Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2019 | 242,449,767 | ||||
| Net Loss | (417,554) | ||||
| Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2020 | 242,959,567 | ||||
| Ending balance, value at Mar. 31, 2020 | $ 2,430 | 9,184,139 | 156,121 | (10,550,089) | (1,207,399) |
| Debt Discount on Convertible Notes | 68,220 | ||||
| Beginning balance, value at Dec. 31, 2019 | $ 2,427 | 9,168,358 | 79,616 | (10,373,189) | (1,122,788) |
| Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2019 | 242,603,100 | ||||
| Shares issued in connection with the sale of common stock | $ 3 | 15,781 | 15,784 | ||
| Stock Issued During Period, Shares, New Issues | 356,467 | ||||
| Stock-based compensation expense | |||||
| Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture | |||||
| Foreign currency translation adjustment | 76,505 | 76,505 | |||
| Net Loss | (176,900) | (176,900) | |||
| Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2020 | 242,959,567 | ||||
| Ending balance, value at Mar. 31, 2020 | $ 2,430 | 9,184,139 | 156,121 | (10,550,089) | (1,207,399) |
| Debt Discount on Convertible Notes | |||||
| Beginning balance, value at Sep. 30, 2020 | $ 2,463 | 9,508,943 | 52,015 | (11,235,696) | $ (1,672,275) |
| Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2020 | 246,248,723 | 246,248,723 | |||
| Shares issued in connection with the sale of common stock | $ 15 | 84,723 | $ 84,738 | ||
| Stock Issued During Period, Shares, New Issues | 1,450,000 | ||||
| Stock-based compensation expense | $ 31 | 404,969 | 405,000 | ||
| Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture | 3,100,000 | ||||
| Foreign currency translation adjustment | (82,637) | (82,637) | |||
| Net Loss | (639,185) | (639,185) | |||
| Common Stock, Shares, Outstanding, Ending Balance at Dec. 31, 2020 | 250,798,723 | ||||
| Ending balance, value at Dec. 31, 2020 | $ 2,509 | 9,998,635 | (30,622) | (11,874,881) | (1,904,359) |
| Beginning balance, value at Sep. 30, 2020 | $ 2,463 | 9,508,943 | 52,015 | (11,235,696) | $ (1,672,275) |
| Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2020 | 246,248,723 | 246,248,723 | |||
| Net Loss | $ (4,237,022) | ||||
| Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2021 | 254,487,319 | 254,487,319 | |||
| Ending balance, value at Mar. 31, 2021 | $ 2,546 | 13,495,049 | (15,310) | (15,472,718) | $ (1,990,433) |
| Debt Discount on Convertible Notes | 43,475 | ||||
| Beginning balance, value at Dec. 31, 2020 | $ 2,509 | 9,998,635 | (30,622) | (11,874,881) | (1,904,359) |
| Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2020 | 250,798,723 | ||||
| Shares issued in connection with the sale of common stock | 30,476 | 30,476 | |||
| Stock Issued During Period, Shares, New Issues | |||||
| Stock-based compensation expense | $ 37 | 3,422,463 | 3,422,500 | ||
| Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture | 3,688,596 | ||||
| Foreign currency translation adjustment | 15,312 | 15,312 | |||
| Net Loss | (3,597,837) | $ (3,597,837) | |||
| Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2021 | 254,487,319 | 254,487,319 | |||
| Beneficial conversion discount on convertible notes payable | 43,475 | $ 43,475 | |||
| [custom:BeneficialConversionDiscount] | |||||
| Ending balance, value at Mar. 31, 2021 | $ 2,546 | $ 13,495,049 | $ (15,310) | $ (15,472,718) | $ (1,990,433) |
| Condensed Consolidated Statement of Cash Flows - USD ($) | 6 Months Ended | |
| Mar. 31, 2021 | Mar. 31, 2020 | |
| Cash flows from operating activities | ||
| Net Income (loss) | $ (4,237,022) | $ (417,554) |
| Adjustments to reconcile net income/(loss) to net cash from operating activities: | ||
| Stock-based compensation | 3,827,500 | |
| Depreciation expense | 8,986 | 8,066 |
| Amortization of discount | 12,582 | 10,919 |
| Change in operating assets and liabilities: | ||
| Accounts payable | 131,957 | 127,125 |
| Accrued interest payable | 14,603 | 11,463 |
| Receivables | 442 | |
| Pre-Payments | (15,723) | (256) |
| Due to related parties | 93,041 | 112,700 |
| Net cash used in operating activities | (164,076) | (147,095) |
| Cash flows from financing activities | ||
| Due to Affiliates | ||
| Proceeds from issuance of common stock | 115,214 | 68,786 |
| Repayments to related party | (53,821) | |
| Issuance of short term note payable, net of OID | 115,000 | 68,220 |
| Net cash from financing activities | 230,214 | 83,185 |
| Effect of currency translations to cash flow | (66,003) | (8,445) |
| Net change in cash and cash equivalents | 135 | (72,355) |
| Beginning of period | 12 | 74,241 |
| End of period | 147 | 1,886 |
| Supplemental cash flow information | ||
| Interest paid | ||
| Taxes | ||
| Noncash investing and financing activities: | ||
| Debt discount on convertible notes | 43,475 | 68,220 |
| Conversion of loan principal into shares | ||
| BASIS OF PRESENTATION | 6 Months Ended |
| Mar. 31, 2021 | |
| Accounting Policies [Abstract] | |
| BASIS OF PRESENTATION | NOTE 1 – BASIS OF PRESENTATION These consolidated financial statements of Graphene &Solar Technologies Limited (GSTX or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). In the opinion of management, these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Certain information, accounting policies and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to Securities and Exchange Commission (SEC) rules and regulations. These financial statements should be read along with Solar Quartz’s audited financial statements as of September 30, 2020. Going Concern Going Concern Future issuances of the Company’s equity or debt securities will be required for the Company to finance operations and continue as a going concern. The financial statements do not include any adjustments that may result from the outcome of these uncertainties. |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION | 6 Months Ended |
| Mar. 31, 2021 | |
| Accounting Policies [Abstract] | |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION | NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION Principles of Consolidation and Basis of Presentation The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2020. Use of Estimates Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities. Cash and Cash Equivalents Concentrations Derivative Financial Instruments The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows. At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital. There was no derivative activity in fiscal quarter ending March 31, 2020. Therefore, no derivative liabilities were recorded during the quarter ended March 31, 2021. Stock-Based Compensation “Compensation - Stock Compensation,” During the quarter ended March 31, 2021, the Company issued 3,688,596 shares of the Company’s common stock to consultants. Since September 30,2020 the Company has issued a total of 6,788,596 shares of the Company’s common stock to consultants. The fair value of the shares, as determined by reference market price of the Company’s common stock on each grant date, during the quarter ended March 31, 2021aggregated $3,422,500. During the quarter ended March 31, 2019, the Company issued no shares of the Company’s common stock to members of the Board of Directors, employees and consultants. Total stock-based compensation expense was $3,827,450 and $0 for the quarters ended March 31, 2021 and 2020, respectively. Foreign Currency Translations Earnings Per Share Reclassifications |
| CONVERTIBLE NOTES PAYABLE | 6 Months Ended |
| Mar. 31, 2021 | |
| Debt Disclosure [Abstract] | |
| CONVERTIBLE NOTES PAYABLE | NOTE 3 – CONVERTIBLE NOTES PAYABLE The Company’s indebtedness as of March 31,2021 and September 30, 2020 were as follows: Schedule of notes payable Description March 31, 2021 September 30, 2020 Convertible notes $ 202,292 $ 168,967 Notes Payable $ 60,000 $ 60,000 Other loans 5,781 5,632 Notes Payable and Other Loans During 2015 and 2016, the Company executed promissory notes payable with six individuals with an aggregate principal balance of $60,000. The notes were due on demand and included interest at 10%. As of March 31, 2021 and September 30, 2020, the total promissory notes payable balance was $93,701 and $90,710 including accrued interest of $33,701 and $30,710, respectively. On January 15, 2019, the holder of a note with a principal balance of $10,000 made demand for payment. To date, the note has not been paid. During the year ended September 30, 2020 a Company Advisor, loaned the Company $5,781. The loan is a demand note at zero interest. Convertible Notes Payable As of March 31, 2021 and September 30, 2020, noteholders representing $70,747 in outstanding principal had not requested the exchange of shares of common stock. As of March 31, 2021 and September 30, 2020, the exchange obligation payable was $152,965 and $147,673 including accrued interest of $82,217 and $76,926, respectively. As of March 31, 2020 and September 30, 2020, the exchange obligation was for 46,213 shares and 44,614 shares of common stock, respectively. On February 1, 2016, the Company issued convertible secured note payable of $30,000 to an individual. The note was due on January 31, 2017 and included interest at 10%. The note was convertible at discretion of the holder into common shares of the Company at the rate of $0.50 per shares. The Company has not extended the maturity date and the note is in default. As of March 31, 2021 and September 30, 2020, the total convertible note payable balance was $46,223 and $43,997, including accrued interest of $16,233 and $13,997 respectively. As of March 31, 2021 and 2019, the exchange obligation was for 92,446 shares and 87,994 shares of common stock, respectively. On December 5, 2019, the Company issued a convertible note payable in the amount of $68,220. The convertible note bear interest at 10% and matures on December 5, 2021 the principal and accrued interest of this convertible note can be converted at the discretion of the holder into common shares at 45% discount to the ADR 20 days prior to notification of conversion. The majority shareholder agreed to increase authorized shares if needed in order to settle this debt. This note was discounted for the full amount and the amount of amortization during the period was $7,430. On October 2, 2020, the Company closed a Securities Purchase Agreement with Geneva Roth Remark Holdings Inc (“GRRH”). In connection therewith, the Company issued GRRH a convertible note payable in the amount of $68,000. The note, including interest at 10%, matures on September 24, 2020. After 180 days, being from March 23, 2021, the note is convertible at a conversion price which is at 39% discount to the lowest trading price during the previous twenty trading days prior to the date of a conversion notice. The note contained an original issue discount of $3,000. The majority shareholder agreed to increase authorized shares if needed in order to settle this debt. This note was discounted $43,475 as at March 23, 2021 and the amount of amortization during the period was $1.932. On November 11, 2020, the Company closed a Securities Purchase Agreement with Geneva Roth Remark Holdings Inc (“GRRH”). In connection therewith, the Company issued GRRH a convertible note payable in the amount of $53,000. The note, including interest at 10%, matures on November 11, 2020. After 180 days, the note is convertible at a conversion price which is at 39% discount to the lowest trading price during the previous twenty trading days prior to the date of a conversion notice. As the conversion date had not become effective as of March 31, 2021 no derivative liability was recorded. The note contained an original issue discount of $3,000. There was no amortization expense recognized during the period. |
| RELATED PARTY | 6 Months Ended |
| Mar. 31, 2021 | |
| Related Party Transactions [Abstract] | |
| RELATED PARTY | NOTE 4- RELATED PARTY PGRNZ Limited, a management company controlled by the Company’s Chief Executive Officer, and a Company Director, provides management services to the Company for which the Company is charged $75,000(AUD) quarterly, approximately $56,250 (US). During the three months ended March 31, 2021 and 2020, the Company incurred charges to operations of $16,888 (US) and $16,888 (US), respectively, with respect to this arrangement. As of March 31, 2021 and September 30, 2020, accrued expenses due to PGRNZ and other related parties was $810,116 and $717,075 respectively. |
| STOCKHOLDERS’ EQUITY | 6 Months Ended |
| Mar. 31, 2021 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY | NOTE 5 – STOCKHOLDERS’ EQUITY Other than for Stock based compensation (see Note 2), 1,450,000 new common shares were issued during the six month period ending March 31, 2021 for proceeds totaling $115,214. The Company has a total of 5,778,366 shares that remain approved, reserved and outstanding and not yet issued by the Transfer Agent at March 31, 2021 |
| COMMITMENTS & CONTINGENCIES | 6 Months Ended |
| Mar. 31, 2021 | |
| Commitments and Contingencies Disclosure [Abstract] | |
| COMMITMENTS & CONTINGENCIES | NOTE 6 – COMMITMENTS & CONTINGENCIES Contingencies From time to time, we may be involved in routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate amount of liability, if any, for any claims of any type (either alone or in the aggregate) may materially and adversely affect our financial condition, results of operations and liquidity. In addition, the ultimate outcome of any litigation is uncertain. Any outcome, whether favorable or unfavorable, may materially and adversely affect us due to legal costs and expenses, diversion of management attention and other factors. We expense legal costs in the period incurred. We cannot assure you that additional contingencies of a legal nature or contingencies having legal aspects will not be asserted against us in the future, and these matters could relate to prior, current or future transactions or events. As of March 31, 2021, there were no pending or threatened litigation against the Company. |
| SUBSEQUENT EVENTS | 6 Months Ended |
| Mar. 31, 2021 | |
| Subsequent Events [Abstract] | |
| SUBSEQUENT EVENTS | NOTE 7 – SUBSEQUENT EVENTS During the month of April 2021 additional Common shares of 450,000 were approved at a share price of approximately $0.05 and Commons shares of 100,000 were approved for Stock based compensation to a company advisor at $0.50. |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (Policies) | 6 Months Ended |
| Mar. 31, 2021 | |
| Accounting Policies [Abstract] | |
| Principles of Consolidation and Basis of Presentation | Principles of Consolidation and Basis of Presentation The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2020. |
| Use of Estimates | Use of Estimates Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities. |
| Cash and Cash Equivalents | Cash and Cash Equivalents |
| Concentrations | Concentrations |
| Derivative Financial Instruments | Derivative Financial Instruments The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows. At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital. There was no derivative activity in fiscal quarter ending March 31, 2020. Therefore, no derivative liabilities were recorded during the quarter ended March 31, 2021. |
| Stock-Based Compensation | Stock-Based Compensation “Compensation - Stock Compensation,” During the quarter ended March 31, 2021, the Company issued 3,688,596 shares of the Company’s common stock to consultants. Since September 30,2020 the Company has issued a total of 6,788,596 shares of the Company’s common stock to consultants. The fair value of the shares, as determined by reference market price of the Company’s common stock on each grant date, during the quarter ended March 31, 2021aggregated $3,422,500. During the quarter ended March 31, 2019, the Company issued no shares of the Company’s common stock to members of the Board of Directors, employees and consultants. Total stock-based compensation expense was $3,827,450 and $0 for the quarters ended March 31, 2021 and 2020, respectively. |
| Foreign Currency Translations | Foreign Currency Translations |
| Earnings Per Share | Earnings Per Share |
| Reclassifications | Reclassifications |
| CONVERTIBLE NOTES PAYABLE (Tables) | 6 Months Ended |
| Mar. 31, 2021 | |
| Debt Disclosure [Abstract] | |
| Schedule of notes payable | The Company’s indebtedness as of March 31,2021 and September 30, 2020 were as follows: Schedule of notes payable Description March 31, 2021 September 30, 2020 Convertible notes $ 202,292 $ 168,967 Notes Payable $ 60,000 $ 60,000 Other loans 5,781 5,632 |
| Schedule of notes payable (Details) - USD ($) | Mar. 31, 2021 | Sep. 30, 2020 |
| Debt Disclosure [Abstract] | ||
| Convertible notes | $ 202,292 | $ 168,967 |
| Notes Payable | 60,000 | 60,000 |
| Other loans | $ 5,781 | $ 5,632 |
